| 6LUB: reference: CH7233163 overcomes osimertinib resistant EGFR-Del19/T790M/C797S mutation., Kashima K, Kawauchi H, Tanimura H, Tachibana Y, Chiba T, Torizawa T, Sakamoto H, Mol Cancer Ther. 2020 Sep 17. pii: 1535-7163.MCT-20-0229. doi:, 10.1158/1535-7163.MCT-20-0229. PMID: 32943545 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).